Details for 2011707284

Up to date per 05.04.2026

Actions

Title / Product Name

APIXABAN-FORMULIERUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011707284

EP Publication Number

2538925

E-Number

765176

Language

PCT Number

US11025994

Publication Date

02.01.2013 A

16.12.2015 B1

Registration Date

16.12.2015

AT Publication Date

15.01.2016

Application Date

24.02.2011

Registration Number

Priorities

25.02.2010

308056 P

IPC

A61K 9/28 20060101AFI20150522BHEP

Maximum Duration of Protection

24.02.2031

Owner

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANYHinterbergstraße 166312 SteinhausenCH

Pfizer Inc.235 East 42nd Street New York, NY 10017US

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1) 1070 WienAT

Inventor

PATEL, Jatinc/o Bristol-Myer Squibb Company Route 206 and Province Line Road Princeton, NJ 08543US

FROST, Charlesc/o Bristol-Myer Squibb Company Route 206 And Province Line Road Princeton, NJ 08543US

JIA, Jingpinc/o Bristol-Myer Squibb Company Route 206 and Province Line Road Princeton, NJ 08543US

VEMA-VARAPU, Chandrac/o Bristol-Myer Squibb Company Route 206 and Province Line Road Princeton, NJ 08543US